Printed From BioPortfolio.com
After surging on lung cancer data, Ignyta looks to raise $160m
08:14 EDT 20 Oct 2017 | pharmaphorum
San Diego based biotech firm Ignyta is capping off a week of success with a public stock offering to raise around $160 million. It specialises in precision medicine cancer drugs, and enjoyed a huge surge in its share price earlier this week when i...
Original Article: After surging on lung cancer data, Ignyta looks to raise $160m
